Association between components of the insulin-like growth factor system and epithelial ovarian cancer risk

Oncology

Volumn 67, Issue 3-4, 2004, Pages 225-230

  Dal Maso, Luigino ^a   Augustin, Livia S A ^a,c   Franceschi, Silvia ^d   Talamini, Renato ^a   Polesel, Jerry ^a   Kendall, Cyril W C ^c   Jenkins, David J A ^c   Vidgen, Ed ^c   Vecchia, Carlo La ^b  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Case control study; IGF I; IGFBP 1; IGFBP 3; Ovarian cancer

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ACUTE DISEASE; ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; CARCINOGENESIS; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; EPITHELIUM TUMOR; FEMALE; HISTOLOGY; HOSPITAL; HOSPITAL ADMISSION; HUMAN; INTERVIEW; ITALY; MULTIVARIATE ANALYSIS; OVARY CANCER; PRIORITY JOURNAL; QUESTIONNAIRE; VALIDATION PROCESS;

ADULT; AGED; CARCINOMA; CASE-CONTROL STUDIES; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; ITALY; MALE; MIDDLE AGED; ODDS RATIO; OVARIAN NEOPLASMS; RISK ASSESSMENT; RISK FACTORS; SOMATOMEDINS;

EID: 9244262528     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000081322     Document Type: Article

References (38)

1. Riman T, Persson I, Nilsson S: Hormonal aspects of epithelial ovarian cancer: Review of epidemiological evidence. Clin Endocrinol (Oxf) 1998;49:695-707.
2. La Vecchia C: Epidemiology of ovarian cancer: A summary review. Eur J Cancer Prev 2001;10:125-129.
3. Chiaffarino F, Pelucchi C, Parazzini F, Negri E, Franceschi S, Talamini R, Conti E, Montella M, La Vecchia C: Reproductive and hormonal factors and ovarian cancer. Ann Oncol 2001;12:337-341.
4. Risch HA: Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst 1998;90:1774-1786.
5. Karasik A, Menczer J, Pariente C, Kanety H: Insulin-like growth factor-I (IGF-I) and IGFbinding protein-2 are increased in cyst fluids of epithelial ovarian cancer. J Clin Endocrinol Metab 1994;78:271-276.
6. Beck EP, Russo P, Gliozzo B, Jaeger W, Papa V, Wildt L, Pezzino V, Lang N: Identification of insulin and insulin-like growth factor I (IGF I) receptors in ovarian cancer tissue. Gynecol Oncol 1994;53:196-201.
7. Hofmann J, Wegmann B, Hackenberg R, Kunzmann R, Shulz KD, Haveman K: Production of insulin-like growth factor binding proteins by human ovarian carcinoma cells. J Cancer Res Clin Oncol 1994;120:137-142.
8. Flyvbjerg A, Mogensen O, Mogensen B, Nielsen OS: Elevated serum insulin-like growth factor-binding protein 2 (IGFBP-2) and decreased IGFBP-3 in epithelial ovarian cancer: Correlation with cancer antigen 125 and tumor-associated trypsin inhibitor. J Clin Endocrinol Metab 1997;82:2308-2313.
9. Lukanova A, Lundin E, Toniolo P, Micheli A, Akhmedkhanov A, Rinaldi S, Muti P, Lenner P, Biessy C, Krogh V, Zeleniuch-Jacquotte A, Berrino F, Hallmans G, Riboli E, Kaaks R: Circulating levels of insulin-like growth factor-I and risk of ovarian cancer. Int J Cancer 2002;101:549-554.
10. Lukanova A, Lundin E, Micheli A, Akhmedkhanov A, Rinaldi S, Muti P, Lenner P, Biessy C, Krogh V, Riboli E, Hallmans G, Berrino F, Zeleniuch-Jacquotte A, Toniolo P, Kaaks R: Risk of ovarian cancer in relation to prediagnostic levels of C-peptide, insulin-like growth factor binding proteins-1 and -2 (USA, Sweden, Italy). Cancer Causes Control 2003;14:285-292.
11. Franceschi S, Barbone F, Negri E, Decarli A, Ferraroni M, Filiberti R, Giacosa A, Gnagnarella P, Nanni O, Salvini S: Reproducibility of an Italian food frequency questionnaire for cancer studies. Results for specific nutrients. Ann Epidemiol 1995;5:69-75.
12. Thierry van Dessel HJHM, Chandrasekher Y, Yap OWS, Lee PDK, Hintz RL, Faessen GHJ, Braat DDM, Fauser BCJM, Giudice LC: Serum and follicular fluid levels of insulin-like growth factor I (IGF-I), IGF-II, and IGF-binding protein-1 and -3 during the normal menstrual cycle. J Clin Endocrinol 1996;81:1224-1231.
13. LeRoith D, Roberts CT Jr: The insulin-like growth factor system and cancer. Cancer Lett 2003;195:127-137.
14. Yee D, Lee AV: Crosstalk between the insulin-like growth factors and estrogens in breast cancer. J Mammary Gland Biol Neoplasia 2000;5:107-115.
15. Klotz DM, Hewitt SC, Ciana P, Raviscioni M, Lindzey JK, Foley J, Maggi A, DiAugustine RP, Korach KS: Requirement of estrogen receptor-alpha in insulin-like growth factor-1 (IGF-1)-induced uterine responses and in vivo evidence for IGF-1/estrogen receptor crosstalk. J Biol Chem 2002;277:8531-8537.
16. Nestler JE, Powers LP, Matt DW, Steingold KA, Plymate SR, Rittmaster RS, Clore JN, Blackard WG: A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J Clin Endocrinol Metab 1991;72:83-89.
17. Plymate SR, Hoop RC, Jones RE, Matej LA: Regulation of sex hormone-binding globulin production by growth factors. Metabolism 1990;39:967-970.
18. Katsaros D, Yu H, Levesque MA, Danese S, Genta F, Richiardi G, Fracchioli S, Khosravi MJ, Diamandi A, Gordini G, Diamandis EP, Massobrio M: IGFBP-3 in epithelial ovarian carcinoma and its association with clinicopathological features and patient survival. Eur J Cancer 2001;37:478-485.
19. Juul A, Scheike T, Pedersen AT, Main KM, Andersson AM, Pedersen LM, Skakkebaek NE: Changes in serum concentrations of growth hormone, insulin, insulin-like growth factor and insulin-like growth factor-binding proteins 1 and 3 and urinary growth hormone excretion during the menstrual cycle. Hum Reprod 1997;12:2123-2128.
20. Underwood LE, Thissen JP, Lemozy S, Ketelslegers JM, Clemmons DR: Hormonal and nutritional regulation of IGF-I and its binding proteins. Horm Res 1994;42:145-151.
21. Lee PD, Giudice LC, Conover CA, Powell DR: Insulin-like growth factor binding protein-1: Recent findings and new directions. Proc Soc Exp Biol Med 1997;216:319-357.
22. Elgin RG, Busby WH Jr, Clemmons DR: An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I. Proc Natl Acad Sci USA 1987;84:3254-3258.
23. Busby WH, Hossenlopp P, Binoux M, Clemmons DR: Purified preparations of the amniotic fluid-derived insulin-like growth factor-binding protein contain multimeric forms that are biologically active. Endocrinology 1989;125:773-777.
24. Signorello LB, Brismar K, Bergstrom R, Andersson S-O, Wolk A, Trichopoulos D, Adami HO: Insulin-like growth factor-binding protein-1 and prostate cancer. J Natl Cancer Inst 1999;91:1965-1967.
25. Augustin LSA, Dal Maso L, Franceschi S, Talamini R, Kendall CWC, Jenkins DJA, Vidgen E, Martini P, La Vecchia C: Association between components of the insulin-like growth factor (IGF) system and endometrial cancer risk. Oncology 2004;67:54-59.
26. McKeown-Eyssen G: Epidemiology of colorectal cancer revisited: Are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol Biomarkers Prev 1994;3:687-695.
27. Giovannucci E: Insulin and colon cancer. Cancer Causes Control 1995;6:164-179.
28. Ullrich A, Gray A, Tam AW, Yang-Feng T, Tsubokawa M, Collins C, Henzel W, Le Bon T, Kathuria S, Chen E, et al: Insulin-like growth factor I receptor primary structure: Comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J 1986;5:2503-2512.
29. Kaaks R, Lukanova A: Energy balance and cancer: The role of insulin and insulin-like growth factor-I. Proc Nutr Soc 2001;60:91-106.
30. Tran TT, Medline A, Bruce RW: Insulin promotion of colon tumors in rats. Cancer Epidemiol Biomarkers Prev 1996;5:1013-1015.
31. Augustin LS, Franceschi S, Jenkins DJ, Kendall CW, La Vecchia C: Glycemic index in chronic disease: A review. Eur J Clin Nutr 2002;56:1049-1071.
32. Holmes MD, Pollak MN, Hankinson SE: Lifestyle correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. Cancer Epidemiol Biomarkers Prev 2002;11:862-867.
33. Holmes MD, Pollak MN, Willett WC, Hankinson SE: Dietary correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. Cancer Epidemiol Biomarkers Prev 2002;11:852-861.
34. Giovannucci E, Pollack M, Liu Y, Platz EA, Mjeed N, Rimm EB, Willett WC: Nutritional predictors of insulin-like growth factor I and their relationship to cancer in men. Cancer Epidemiol Biomarkers Prev 2003;12:84-89.
35. Bidoli E, La Vecchia C, Montella M, Dal Maso L, Conti E, Negri E, Scarabelli C, Carbone A, Decarli A, Franceschi S: Nutrient intake and ovarian cancer: An Italian case-control study. Cancer Causes Control 2002;13:255-261.
36. Augustin LS, Polesel J, Bosetti C, Kendall CW, La Vecchia C, Parpinel M, Conti E, Montella M, Franceschi S, Jenkins DJ, Dal Maso L: Dietary glycemic index, glycemic load and ovarian cancer risk: A case-control study in Italy. Ann Oncol 2003;14:78-84.
37. Rodriguez C, Calle EE, Fakhrabadi-Shokoohi D, Jacobs EJ, Thun MJ: Body mass index, height, and the risk of ovarian cancer mortality in a prospective cohort of postmenopausal women. Cancer Epidemiol Biomarkers Prev 2002;11:822-828.
38. Dal Maso L, Franceschi S, Negri E, Conti E, Montella M, Vaccarella S, Canzonieri V, Parazzini F, La Vecchia C: Body size indices at different ages and epithelial ovarian cancer risk. Eur J Cancer 2002;38:1769-1774.